» Articles » PMID: 38086891

SurviveR: a Flexible Shiny Application for Patient Survival Analysis

Overview
Journal Sci Rep
Specialty Science
Date 2023 Dec 12
PMID 38086891
Authors
Affiliations
Soon will be listed here.
Abstract

Kaplan-Meier (KM) survival analyses based on complex patient categorization due to the burgeoning volumes of genomic, molecular and phenotypic data, are an increasingly important aspect of the biomedical researcher's toolkit. Commercial statistics and graphing packages for such analyses are functionally limited, whereas open-source tools have a high barrier-to-entry in terms of understanding of methodologies and computational expertise. We developed surviveR to address this unmet need for a survival analysis tool that can enable users with limited computational expertise to conduct routine but complex analyses. surviveR is a cloud-based Shiny application, that addresses our identified unmet need for an easy-to-use web-based tool that can plot and analyse survival based datasets. Integrated customization options allows a user with limited computational expertise to easily filter patients to enable custom cohort generation, automatically calculate log-rank test and Cox hazard ratios. Continuous datasets can be integrated, such as RNA or protein expression measurements which can be then used as categories for survival plotting. We further demonstrate the utility through exemplifying its application to a clinically relevant colorectal cancer patient dataset. surviveR is a cloud-based web application available at https://generatr.qub.ac.uk/app/surviveR , that can be used by non-experts users to perform complex custom survival analysis.

Citing Articles

ClassifieR 2.0: expanding interactive gene expression-based stratification to prostate and high-grade serous ovarian cancer.

McCabe A, Quinn G, Jain S, O Dalaigh M, Dean K, Murphy R BMC Bioinformatics. 2024; 25(1):362.

PMID: 39574035 PMC: 11580654. DOI: 10.1186/s12859-024-05981-6.


SurvInt: a simple tool to obtain precise parametric survival extrapolations.

Gallacher D BMC Med Inform Decis Mak. 2024; 24(1):76.

PMID: 38486175 PMC: 10938652. DOI: 10.1186/s12911-024-02475-6.

References
1.
Allen W, Dunne P, McDade S, Scanlon E, Loughrey M, Coleman H . Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapy. JCO Precis Oncol. 2018; 2018. PMC: 6040635. DOI: 10.1200/PO.17.00241. View

2.
Guinney J, Dienstmann R, Wang X, De Reynies A, Schlicker A, Soneson C . The consensus molecular subtypes of colorectal cancer. Nat Med. 2015; 21(11):1350-6. PMC: 4636487. DOI: 10.1038/nm.3967. View

3.
Quinn G, Sessler T, Ahmaderaghi B, Lambe S, Vansteenhouse H, Lawler M . classifieR a flexible interactive cloud-application for functional annotation of cancer transcriptomes. BMC Bioinformatics. 2022; 23(1):114. PMC: 8974006. DOI: 10.1186/s12859-022-04641-x. View

4.
Becht E, Giraldo N, Lacroix L, Buttard B, Elarouci N, Petitprez F . Erratum to: Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016; 17(1):249. PMC: 5134277. DOI: 10.1186/s13059-016-1113-y. View

5.
Lanczky A, Gyorffy B . Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation. J Med Internet Res. 2021; 23(7):e27633. PMC: 8367126. DOI: 10.2196/27633. View